Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Viruses ; 16(9)2024 Sep 14.
Article in English | MEDLINE | ID: mdl-39339937

ABSTRACT

(1) Background: early in the COVID-19 pandemic, reverse transcription polymerase chain reaction (RT-PCR) testing was limited. Assessing seroprevalence helps understand prevalence and reinfection risk. However, such data are lacking for the first epidemic wave in Belgian nursing homes. Therefore, we assessed SARS-CoV-2 seroprevalence and cumulative RT-PCR positivity in Belgian nursing homes and evaluated reinfection risk. (2) Methods: we performed a cross-sectional study in nine nursing homes in April and May 2020. Odds ratios (ORs) were calculated to compare the odds of (re)infection between seropositive and seronegative participants. (3) Results: seroprevalence was 21% (95% CI: 18-23): 22% (95% CI: 18-25) in residents and 20% (95% CI: 17-24) in staff. By 20 May 2020, cumulative RT-PCR positivity was 16% (95% CI: 13-21) in residents and 8% (95% CI: 6-12) in staff. ORs for (re)infection in seropositive (compared to seronegative) residents and staff were 0.22 (95% CI: 0.06-0.72) and 3.15 (95% CI: 1.56-6.63), respectively. (4) Conclusion: during the first wave, RT-PCR test programmes underestimated the number of COVID-19 cases. The reinfection rate in residents was 3%, indicating protection, while it was 21% in staff, potentially due to less cautious health behaviour. Future outbreaks should use both RT-PCR and serological testing for complementary insights into transmission dynamics.


Subject(s)
COVID-19 , Nursing Homes , SARS-CoV-2 , Humans , Belgium/epidemiology , COVID-19/epidemiology , COVID-19/transmission , COVID-19/virology , Nursing Homes/statistics & numerical data , Seroepidemiologic Studies , SARS-CoV-2/immunology , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Female , Male , Cross-Sectional Studies , Aged , Middle Aged , Aged, 80 and over , Antibodies, Viral/blood , Adult , Reinfection/epidemiology , Reinfection/virology , Health Personnel/statistics & numerical data , COVID-19 Serological Testing , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL